2021 Fall Conference | L1 - Leading in a Post-pandemic World: Strategies For Your Success
Program Materials Program Evaluations
| 11:00 AM - 11:05 AM EDT | Introduction |
Introduction
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN, Jennifer L. Hopp, MD, FAAN, Barbara L. Hoese, , |
| 11:05 AM - 11:30 AM EDT | Speaker |
The Language of Leadership
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN, Jennifer L. Hopp, MD, FAAN, , , Barbara L. Hoese |
| 11:30 AM - 11:55 AM EDT | Speaker |
Relationship Building and Effective Communication
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN, Jennifer L. Hopp, MD, FAAN, Barbara L. Hoese, , |
| 11:55 AM - 12:20 PM EDT | Discussion |
Navigating Conflict
Barbara L. Hoese |
| 12:20 PM - 12:30 PM EDT | Closing Remarks |
Closing Remarks
Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN, Jennifer L. Hopp, MD, FAAN, Barbara L. Hoese, , |
| Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN | Dr. De Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurology Academy. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. De Luca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. De Luca has received research support from NIHR, BRC (Oxford). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). The institution of Dr. De Luca has received research support from UK MS Society. The institution of Dr. De Luca has received research support from Oxford-Quinnipiac Partnership. The institution of Dr. De Luca has received research support from US Department of Defense. The institution of Dr. De Luca has received research support from Wellcome ISSF (Oxford). The institution of Dr. De Luca has received research support from Bristol Myers Squibb. The institution of Dr. De Luca has received research support from University of Oxford (John Fell Fund). The institution of Dr. De Luca has received research support from National Health and Medical Research (Australia). Dr. De Luca has a non-compensated relationship as a Editorial board member with MS Journal that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Vice-Chair of Grant Review Panel with UK MS Society that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Steering Group member with MS Academy that is relevant to AAN interests or activities. Dr. De Luca has a non-compensated relationship as a Board of Directors with SEQUINS that is relevant to AAN interests or activities. |
| Jennifer L. Hopp, MD, FAAN | Dr. Hopp has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for GOODELL, DEVRIES, LEECH & DANN, LLP. The institution of Dr. Hopp has received research support from MII TA Grant 20180828 TEDCO EpiWatch: A Mobile Health Application for Epilepsy Management. The institution of Dr. Hopp has received research support from MII TA Grant TEDCO Project #0723-012 EPIScalp; A Novel Tool for Diagnosing Epilepsy from Scalp EEG. Dr. Hopp has received publishing royalties from a publication relating to health care. Dr. Hopp has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty with J. Kiffin Penry Epilepsy 好色先生al Programs. |
| Barbara L. Hoese | Barbara L. Hoese has nothing to disclose. |
| No disclosure on file |